Recro Pharma Submits New Drug Application for IV Meloxicam 30mg
July 31, 2017 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., July 31, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma Reports Inducement Grants for New Staff
July 21, 2017 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., July 21, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma Reports Inducement Grants for New Staff
July 10, 2017 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., July 10, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma Acquires Novel Neuromuscular Blocking Agents
July 05, 2017 08:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., July 05, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma Added to the Russell 3000® Index
June 26, 2017 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., June 26, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma to Participate in Hospital Drug Launch Panel at the JMP Life Sciences Conference
June 16, 2017 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., June 16, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma Reports Inducement Grants for New Staff
June 15, 2017 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., June 15, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma Appoints Ryan D. Lake as Senior Vice President of Finance and Chief Accounting Officer
June 06, 2017 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., June 06, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma to Participate in Upcoming Investor Conferences
June 02, 2017 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., June 02, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma Presents Phase III Bunionectomy Clinical Data for IV Meloxicam at the American Pain Society 36th Annual Scientific Meeting
May 18, 2017 08:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., May 18, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...